The Round
Regenesis-OS is raising a $1.5M pre-seed round to launch hospital pilot partnerships, advance toward FDA clearance, and extend our validated platform.
Use of Funds
Weighted toward the engineering and data work that compounds the platform's clinical edge.
Milestones
Validated at approximately 0.80 AUC, leakage-audited.
External and internal agreement across separate hospital systems, with the pipeline audited for bias.
Clinical collaboration established.
Formal partnership with a hospital system to ground the platform in live clinical workflow.
Prospective silent-alert pilot deployed.
Real-time risk generated alongside care, evaluated silently before it informs decisions.
FDA De Novo pathway initiated.
Begin the regulatory route toward clearance as a novel clinical decision tool.
Investor Materials
Reach out and we will share the overview and answer questions directly.